ES2149036T3 - Sistema a base de derivado acido fosfonico y de metabisulfito para estabilizar el acido ascorbico. - Google Patents

Sistema a base de derivado acido fosfonico y de metabisulfito para estabilizar el acido ascorbico.

Info

Publication number
ES2149036T3
ES2149036T3 ES98401659T ES98401659T ES2149036T3 ES 2149036 T3 ES2149036 T3 ES 2149036T3 ES 98401659 T ES98401659 T ES 98401659T ES 98401659 T ES98401659 T ES 98401659T ES 2149036 T3 ES2149036 T3 ES 2149036T3
Authority
ES
Spain
Prior art keywords
metabisulphite
phosphonic
system based
acid
ascorbic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98401659T
Other languages
English (en)
Inventor
Quang Lan Nguyen
Isabelle Afriat
Dang Man Pham
Florence Chanvin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
L'Oréal SA
Original Assignee
L'Oréal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by L'Oréal SA filed Critical L'Oréal SA
Application granted granted Critical
Publication of ES2149036T3 publication Critical patent/ES2149036T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/23—Sulfur; Selenium; Tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/926—Topical chemical, e.g. cosmetic or sunscreen

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)

Abstract

LA INVENCION SE REFIERE A UN SISTEMA A BASE DE UN DERIVADO FOSFONICO Y DE UN METABISULFITO PARA ESTABILIZAR EL ACIDO ASCORBICO. EL DERIVADO DEL ACIDO FOSFONICO PUEDE SER EN PARTICULAR ACIDO ETILENODIAMINA TETRA ( METILENO FOSFONICO ) , ACIDO HEXAMETILENODIAMINA TETRA ( METILENO FOSFONICO ) , ACIDO DIETILENOTRIAMINA PENTA ( METILENOFOSFONICO ) , O UNA SAL DE TAL ACIDO. EL METABISULFITO ES EN PARTICULAR EL METABISULFITO DE SODIO. LA INVENCION SE REFIERE TAMBIEN A LAS COMPOSICIONES, EN CONCRETO COSMETICA Y DERMATOLOGICA, QUE CONTIENEN ACIDO ASCORBICO Y A ESTE SISTEMA ESTABILIZANTE, Y A LA UTILIZACION DE ESTAS COMPOSICIONES EN LOS SECTORES COSMETICO Y/O DERMATOLOGICO.
ES98401659T 1997-09-02 1998-07-02 Sistema a base de derivado acido fosfonico y de metabisulfito para estabilizar el acido ascorbico. Expired - Lifetime ES2149036T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9710903A FR2767694B1 (fr) 1997-09-02 1997-09-02 Systeme a base de derive d'acide phosphonique et de metabisulfite pour stabiliser l'acide ascorbique et composition contenant un tel systeme

Publications (1)

Publication Number Publication Date
ES2149036T3 true ES2149036T3 (es) 2000-10-16

Family

ID=9510681

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98401659T Expired - Lifetime ES2149036T3 (es) 1997-09-02 1998-07-02 Sistema a base de derivado acido fosfonico y de metabisulfito para estabilizar el acido ascorbico.

Country Status (7)

Country Link
US (1) US6110476A (es)
EP (1) EP0913147B1 (es)
JP (1) JP2993943B2 (es)
KR (1) KR100282539B1 (es)
DE (1) DE69800170T2 (es)
ES (1) ES2149036T3 (es)
FR (1) FR2767694B1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0003166B1 (pt) * 1999-07-16 2015-08-25 Natura Cosmeticos Sa Processo para estabilização de compostos antioxidantes, e composições aquosas
EP1238644A4 (en) * 1999-12-15 2006-04-05 Kyowa Hakko Kogyo Kk STABILIZERS FOR L-ASCORBIC ACID 2-SODIUM PHOSPHATE
WO2001086415A2 (en) 2000-05-08 2001-11-15 Transilica, Inc. Priority in a portable thread environment
US20050136431A1 (en) * 2000-11-03 2005-06-23 Oakley Robert H. Methods of screening compositions for G protein-coupled receptor desensitization inhibitory activity
JP2004331524A (ja) * 2003-05-01 2004-11-25 Nikko Chemical Co Ltd Ｌ−アスコルビン酸脂肪酸エステルの着色及び臭い発生の防止方法及び組成物、及び該方法及び組成物を用いた皮膚外用剤、化粧料、及び入浴剤
US20050065091A1 (en) * 2003-09-18 2005-03-24 Gholam Peyman Stabilized ocular solutions
US20090082305A1 (en) * 2005-03-30 2009-03-26 Kyowa Hakko Kogyo Co., Ltd. Method of improving storage stability of substance
US20070077220A1 (en) * 2005-09-30 2007-04-05 Ramirez Jose E Stable ascorbic acid compositions
US20070178058A1 (en) * 2006-02-02 2007-08-02 Ramirez Jose E Methods of using stable ascorbic acid compositions
US20070269534A1 (en) * 2006-02-02 2007-11-22 Ramirez Jose E Methods of treating skin to enhance therapeutic treatment thereof
CA2642726C (en) * 2006-02-21 2015-11-03 Mary Kay, Inc. Stable vitamin c compositions
CN102099008B (zh) * 2008-07-16 2013-11-20 帝斯曼知识产权资产管理有限公司 包含(乙二胺)四亚甲基磷酸戊钠的化妆品组合物
FR2940609B1 (fr) * 2008-12-30 2011-05-06 Oreal Association de monosaccharides et d'agents desquamants et son utilisation en cosmetique
FR2940615B1 (fr) * 2008-12-30 2011-12-30 Oreal Association de monosaccharides avec des agents antioxydants et son utilisation en cosmetique
FR2940612B1 (fr) * 2008-12-30 2011-05-06 Oreal Association de monosaccharides avec l'acide ascorbique et son utilisation en cosmetique
FR2968955B1 (fr) * 2010-12-15 2012-12-28 Oreal Composition cosmetique comprenant de l'acide ascorbique
JP6017953B2 (ja) * 2012-12-28 2016-11-02 花王株式会社 皮膚外用組成物
JPWO2022034874A1 (es) * 2020-08-11 2022-02-17

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR670157A (fr) * 1928-04-24 1929-11-26 Perfectionnements aux moyens pour sécher, imprégner et traiter similairement le bois
US4243543A (en) 1979-05-11 1981-01-06 Economics Laboratory, Inc. Stabilized liquid enzyme-containing detergent compositions
JP3008719B2 (ja) * 1993-02-23 2000-02-14 和光純薬工業株式会社 アスコルビン酸又は／及びその塩を含む溶液の安定化方法
FR2715844B1 (fr) * 1994-02-04 1996-03-29 Oreal Emulsion contenant de l'acide ascorbique stabilisé, procédé de traitement cosmétique la mettant en Óoeuvre, ses utilisations.

Also Published As

Publication number Publication date
US6110476A (en) 2000-08-29
DE69800170T2 (de) 2000-09-28
FR2767694B1 (fr) 1999-10-08
KR19990029381A (ko) 1999-04-26
EP0913147B1 (fr) 2000-05-31
FR2767694A1 (fr) 1999-03-05
KR100282539B1 (ko) 2001-08-07
JP2993943B2 (ja) 1999-12-27
EP0913147A1 (fr) 1999-05-06
JPH11116423A (ja) 1999-04-27
DE69800170D1 (de) 2000-07-06

Similar Documents

Publication Publication Date Title
ES2142034T3 (es) Compuestos biaromaticos que llevan un grupo adamantilo en orto, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
PA8446001A1 (es) Derivados de n-hidroxi-b-sulfonilpropionamida
ES2169105T3 (es) Agentes antitromboticos tripeptidicos.
ES2084073T3 (es) Aclarados finales libres de cromo para metal fosfatado.
PA8575701A1 (es) Preparaciones acidas de insulina con estabilidad mejorada
ES2126790T3 (es) Composicion cosmetica que comprende una hidrocalcona y retinol o un derivado de este.
ES2106553T3 (es) Composiciones anti-angiogenicas y metodos de uso.
ES2119325T3 (es) Compuestos polienicos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
ES2032899T3 (es) Agente cosmetico para aplicacion externa y su uso.
ATE251108T1 (de) Compositionen auf basis von resveratrolderivaten
ES2110003T3 (es) Nuevas composiciones a base de derivados de la clase de los taxanos.
ES2161886T3 (es) Composiciones en barra de gel que comprenden gelificantes opticamente enriquecidos.
AR021139A1 (es) Acidos nucleicos y polipeptidos de activadores de la transcripcion y metodos de uso de los mismos
ES2119984T3 (es) Nuevos compuestos propinil bi-aromaticos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
ES2092031T3 (es) Composicion transdermica que contiene selegilina.
GT199700052A (es) Sales metanosulfonatode5-(2-4-(1,2-benzoisotiazol-3-il)-piperazinil)etil)-6-cloro-1,3-dihidro-2h-indol-2-onadihidratadas
ES2125535T5 (es) Mezclas, que contienen isocianatos emulsionables en agua.
ES2143734T3 (es) Compuestos bioaromaticos que llevan un grupo adamantilo en para, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
AR003893A1 (es) Composicion cosmetica transparente en barra con 2-metil-1,3-propanodiol.
MX9405434A (es) Composicion de peroxido de hidrogeno.
ES2147427T3 (es) Aminas ciclicas n-sustituidas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
ES2156642T3 (es) Composicion que comprende un derivado de acido cinamico y un polimero poliaminado.
UA10208A (uk) Дерматологічний косметичний засіб
ES2120801T3 (es) Composicion para la deformacion permanente de las fibras queratinicas, que contienen un antagonista de substancia p o un antagonista de cgrp.
ES2122159T3 (es) Composiciones liquidas que comprenden blanqueantes de baja solubilidad acuosa.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 913147

Country of ref document: ES